We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

98 hedge funds and large institutions have $134M invested in Avid Bioservices, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,836% more call options, than puts

Call options by funds: $323K | Put options by funds: $11K

50% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 22

45% more capital invested

Capital invested by funds: $92.1M → $134M (+$41.5M)

33% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 15

1% more funds holding

Funds holding: 9798 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
98
Holders Change
+1
Holders Change %
+1.03%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
20
Increased
33
Reduced
22
Closed
15
Calls
$323K
Puts
$11K
Net Calls
+$312K
Net Calls Change
+$170K

CDMO Hedge Fund Activity: Q2 2019 in Review

98 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2019, worth a combined $134M — up 45% from $92.1M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CDMO positions and 15 closed out — a net gain of 5 holders — while 33 added to existing stakes and 22 trimmed.

The largest buyer was ISZO Capital Management, adding an estimated $6.32M. The largest seller was Roubaix Capital, exiting entirely with an estimated $2.08M sold.

  • 98 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2019, up from 97 in Q1 2019.
  • Funds reported $134M of Avid Bioservices, Inc. Common Stock stock for Q2 2019, up 45% quarter-over-quarter.
  • 20 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2019 and 15 closed out, a net change of +5 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2019 was ISZO Capital Management, an estimated $6.32M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q2 2019 was Roubaix Capital, an estimated $2.08M sold.

Based on aggregated 13F filings for Q2 2019.